While the expression of genes that are normally involved in spermatogenesis is frequently detected in tumors, the extent to which these gene products are required for neoplastic behaviors is unclear. To begin to address their functional relevance to tumorigenesis, we identified a cohort of proteins which display synthetic lethality with paclitaxel in non-small-cell lung cancer and whose expression is biased toward testes and tumors. Remarkably, these testis proteins, FMR1NB, NXF2, MAGEA5, FSIP1, and STARD6, are required for accurate chromosome segregation in tumor cells. Their individual depletion enhances the generation of multipolar spindles, increases mitotic transit time, and induces micronucleation in response to an otherwise innocuous dose of paclitaxel. The underlying basis for abnormal mitosis is an alteration in microtubule function, as their depletion increases microtubule cytaster formation and disrupts microtubule stability. Given these observations, we hypothesize that reactivated testis proteins may represent unique tumor cell vulnerabilities which, if targeted, could enhance responsiveness to antimitotic therapy. Indeed, we demonstrate that combining paclitaxel with a small-molecule inhibitor of the gametogenic and tumor cell mitotic protein TACC3 leads to enhanced centrosomal abnormalities, activation of death programs, and loss of anchorage-independent growth. T umor-specific epigenetic alterations allow the activation of a panoply of otherwise silenced genetic programs that can be exploited to promote neoplastic phenotypes. In particular, genes normally involved in development and gametogenesis are frequently found to be reactivated in tumors, affording an opportunity for transformed cells to co-opt primordial cell features to confer oncogenic behaviors such as self-renewal, uncontrolled proliferation, and epithelial-to-mesenchymal transition (EMT) (1, 39). Cancer testis (CT) antigens represent one group of gametogenic proteins whose expression is otherwise biased toward the testes and reactivated in tumor cells (39). Because the testes are an immune privileged site, humoral and/or cellular responses are often elicited to CT antigens in cancer patients. Thus, much focus has surrounded exploiting these antigens as anticancer vaccine targets, while functional roles, if any, for these proteins in supporting tumor cell fitness have not been extensively evaluated. There are over 200 annotated CT antigens, and most have no known role in spermatogenesis or tumorigenesis (39). However, three recent studies implicate members of the CT antigen family in tumorigenic processes, including p53 turnover, centrosome coalescence, mitotic progression, and regulation of retinoic acid signaling (10,12,43). Furthermore, high expression of specific CT antigens in tumors has been correlated with significantly poorer outcomes, suggesting that their reactivation may enhance aggressiveness or chemoresistance (8,12,43). Therefore, uncovering roles for CT antigens and other ectopically expressed gametogenic genes could si...